South Korea Biopsy System Market was valued at USD 0.4 Billion in 2022 and is projected to reach USD 0.6 Billion by 2030, growing at a CAGR of 6.3% from 2024 to 2030.
Â
The South Korea Biopsy System Market is experiencing significant growth, driven by the increasing prevalence of cancer and advancements in diagnostic technologies. In 2023, the market generated a revenue of USD 31.4 million and is projected to reach USD 64.3 million by 2030, reflecting a compound annual growth rate (CAGR) of 10.8% from 2024 to 2030. citeturn0search0
Needle-based biopsy guns emerged as the leading product segment in 2023, attributed to their precision and minimally invasive nature. This segment is anticipated to maintain its dominance, registering the fastest growth during the forecast period. citeturn0search0
The rising incidence of cancer in South Korea underscores the critical need for efficient diagnostic tools. Approximately 240,000 new cancer cases are reported annually, highlighting the demand for advanced biopsy systems. citeturn0search2
Technological advancements in molecular diagnostics, such as next-generation sequencing and digital PCR, have enhanced the accuracy and efficiency of biopsy procedures. These innovations enable early detection and personalized treatment plans, aligning with the healthcare industry's shift towards precision medicine. citeturn0search2
Government initiatives play a pivotal role in market expansion. The South Korean government's support for research and development in cancer diagnostics fosters innovation and facilitates the integration of cutting-edge technologies into clinical practice. citeturn0search2
The preference for non-invasive diagnostic methods among patients has led to increased adoption of liquid biopsy techniques. This approach offers a less invasive alternative to traditional tissue biopsies, enhancing patient comfort and compliance. citeturn0search2
In the regulatory landscape, the Ministry of Food and Drug Safety (MFDS) approved 711 Investigational New Drug (IND) applications in 2022, with 49% being global trials. This reflects South Korea's growing prominence in the global clinical research arena. citeturn0search4
The South Korea Biopsy System Market is poised for substantial growth, driven by technological advancements, supportive government policies, and a rising demand for non-invasive diagnostic solutions. These factors collectively contribute to the market's expansion and the enhancement of cancer diagnostic capabilities within the country.
Get an In-Depth Research Analysis of the South Korea Biopsy System Market Size And Forecast [2025-2032]
Â
Hologic
Siemens
Invivo
Planmed
METALTRONICA
Hologic
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Biopsy System Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Biopsy System Market
Needle Biopsy
Surgical Biopsy
Endoscopic Biopsy
Image-guided Biopsy
Biopsy Needles
Biopsy Guns
Biopsy Forceps
Biopsy Kits
Biopsy Trays
Breast Cancer Biopsy
Lung Cancer Biopsy
Prostate Cancer Biopsy
Skin Cancer Biopsy
Gastrointestinal Cancer Biopsy
Core Needle Biopsy
Vacuum-Assisted Biopsy
Fine Needle Aspiration
Excisional Biopsy
Hospitals
Diagnostic Laboratories
Ambulatory Surgical Centers
Clinics
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Biopsy System Market Research Analysis
1. Introduction of the South Korea Biopsy System Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Biopsy System Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Biopsy System Market, By Type
6. South Korea Biopsy System Market, By Application
7. South Korea Biopsy System Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Biopsy System Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/